<!DOCTYPE html>
<html lang="en">

<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>New Childhood Vaccine Approved | Medi Plus Blog</title>
  <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.3/dist/css/bootstrap.min.css" rel="stylesheet" />


  <!-- REBRANDING JS -->
  <script src="branding-update.js"></script>

  
  <!-- CSS -->
     <link rel="stylesheet" href="css/style.css">


  <style>
    .article-header {
      background-color: #1c66aa;
      color: white;
      padding: 2.5rem 2rem;
    }

    .article-meta {
      font-size: 0.9rem;
      color: #eee;
    }

    .lead-img {
      max-height: 300px;
      object-fit: cover;
    }
  </style>
</head>

<body>

  <!-- Medivanta Loader -->
<div id="medivantaLoader">
  <div class="loaderContent">
    <img src="images/caduceus-medical-symbol-blue-background-9299141.webp" alt="Medivanta Logo" width="80">
  </div>
</div>


  <!-- Header -->
  <div class="article-header text-center">
    <h1 class="display-6">New Childhood Vaccine Approved</h1>
    <p class="article-meta">Posted: July 1, 2025 &bullet; Category: Public Health</p>
  </div>

  <!-- Article Body -->
  <div class="container my-5">
    <img src="images/blogpost3.webp" class="img-fluid mb-4 lead-img" alt="Childhood Vaccine Update" />

    <p class="lead">Starting August 2025, children aged 6â€“12 will be eligible for a newly approved vaccine designed to
      protect against respiratory syncytial virus (RSV) and other seasonal infections. This marks a major step forward
      in pediatric public health.</p>

    <h4>ğŸ§¬ Whatâ€™s in the New Vaccine?</h4>
    <p>The vaccine combines protection against RSV, influenza, and pneumococcal infections â€” three of the most common
      causes of hospitalization in children. Itâ€™s administered as a single dose and has shown strong immune response in
      clinical trials.</p>

    <h4>ğŸ“Š Trial Results</h4>
    <ul>
      <li>Effectiveness: 89% protection against RSV-related hospitalization</li>
      <li>Side Effects: Mild fever and soreness in 12% of cases</li>
      <li>Duration: Immunity lasts up to 12 months</li>
    </ul>

    <h4>ğŸ‘©â€âš•ï¸ Expert Opinion</h4>
    <p>Dr. Joy Nwachukwu, pediatric immunologist at Medi Plus, says: <em>â€œThis vaccine simplifies protection for
        school-aged children and reduces the burden on families and clinics.â€</em></p>

    <h4>ğŸ“… Rollout Timeline</h4>
    <p>The vaccine will be available at Medi Plus clinics starting August 15, 2025. Parents are encouraged to book
      appointments early, especially before school resumes.</p>

    <h5 class="mt-5">ğŸ’¡ Did You Know?</h5>
    <p>RSV affects nearly 90% of children before age 2. While most cases are mild, severe infections can lead to
      pneumonia and require hospitalization.</p>

    <a href="medicalnews.html" class="btn btn-outline-primary mt-4">&larr; Back to Blog</a>
  </div>

  <!-- Bootstrap JS -->
  <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.3.3/dist/js/bootstrap.bundle.min.js"></script>
</body>

</html>